Some of the ways the information has been categorised has changed over time, leading to further inconsistencies in counting the data.
Determining whether the upregulation of mGluR5 in children with autism is associated with neuronal or astrocytic expression will be key to categorising this change as a relevant or confounding factor in the interpretation of BOLD signal differences.
Univariate analysis of the gene copy number changes, categorised as gain, loss, or no change, showed a significant relationship to progression free survival for MRPS23 (p = 0.0002), PDK2 (p = 0.004), and MSN (p = 0.016).
Reviews that were judged as having a major change were categorised as having a changed conclusion.
When the change in task difficulty scores over 12 months were categorised according to change in general health status, the Jonckheere-Terpstra test found no significant trend in the order of the median scores (p = 0.064).
As an alternative model to compare the effects of large changes in temperature on mortality with moderate changes, temperature change was categorised into 3 groups: a drop of more than 3°C; a rise of more than 3°C; a change in either direction of less than 3°C.
Figure 3 shows the relation between exposure dose and outcome, with randomised controlled trials categorised by the change in percentage fat intake between the intervention and control groups.
Body pattern choices were categorised as "no change" (remaining in a darkened mottle pattern), "deimatic display" (darkened mottle pattern accompanied by larger dark spots or dark stripes along the side of the mantle) (Moynihan, 1983; Hanlon and Messenger, 1996), "transparent" (body colour change to transparent), and "flash" (squid produces a rapid succession of body patterns) (Moynihan, 1983).
Using these minimal important change scores, each participant was categorised as showing no change or a positive or negative change on each questionnaire.
Nevertheless, Risse et al. [22] described the importance of the qualitative assessment of the contrast time course component when analysing contrast-enhanced 3D MRI to categorise perfusion changes as normal, delayed, reduced, reduced and delayed as well as perfusion loss [22].
Cases with histopathological characteristics of chemotherapy exposure – as described above – but a macroscopic residual tumour mass were categorised as histopathological changes in a macroscopic residual tumour mass (pHRTM).
